Tag: cell therapy human raw materials market growth

  • 2024-2033 Global Cell Therapy Human Raw Materials Market Outlook: Projected Size and Growth Rate

    2024-2033 Global Cell Therapy Human Raw Materials Market Outlook: Projected Size and Growth Rate

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Cell Therapy Human Raw Materials Market from 2024 to 2033?
    The cell therapy human raw materials market has grown substantially in recent years. It is anticipated to rise from $2.34 billion in 2023 to $2.81 billion in 2024, at a CAGR of 20.1%. Contributing factors include a higher incidence of chronic diseases, an aging population, increased demand for regenerative medicines, government support and funding, and rising healthcare expenses.

    The cell therapy human raw materials market is projected for significant growth, anticipated to reach $5.86 billion by 2028 with a CAGR of 20.2%. This growth is attributed to expanding therapeutic applications, heightened patient awareness, favorable regulations, a booming biopharmaceutical sector, and improved manufacturing. Trends include the adoption of allogeneic therapies, AI integration, off-the-shelf cell therapies, 3D bioprinting technology, and hybrid cell therapy development.

    Claim Your Free Sample of the Global Cell Therapy Human Raw Materials Market Report Today!
    https://www.thebusinessresearchcompany.com/sample.aspx?id=15759&type=smp

    What Key Factors Are Fueling the Growth of the Cell Therapy Human Raw Materials Market?
    The rising adoption of regenerative medicine is expected to drive the cell therapy human raw materials market. Regenerative medicine leverages the body’s regenerative abilities or external stimuli to repair tissues. Its visibility is growing due to advancements in biotechnology and personalized medicine demand. Cell therapy human raw materials provide essential components for these therapies. A report noted a significant increase in the number of therapeutic developers in regenerative medicine, with financing reaching $22.7 billion in 2021. Thus, the rising adoption of regenerative medicine is driving this market.

    What Are the Major Segments of the Cell Therapy Human Raw Materials Market?
    1) By Product: Cell Culture Media, Cell Culture Sera, Cell Culture Supplements, Reagents And Buffers, Other Raw Materials
    2) By Type Of Cell Therapy: Dendritic Cell Therapy, Natural Killer (NK) Cell Therapy, Stem Cell Therapy, T-Cell Therapy
    3) By End-Use: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organization (CMOs), Academic And Research Institutions

    What New Trends Are Transforming the Cell Therapy Human Raw Materials Market?
    In the cell therapy human raw materials market, companies are focusing on creating chemically defined cell culture media to speed up therapy development. In May 2023, Lonza Group AG launched the TheraPEAK T-VIVO Cell Culture Medium, featuring a serum-free, animal component-free formulation that ensures safety and regulatory compliance.

    Order Now for Fast Delivery of Your Cell Therapy Human Raw Materials Market Report!
    https://www.thebusinessresearchcompany.com/report/cell-therapy-human-raw-materials-global-market-report

    Which Regions Are Driving Growth in the Cell Therapy Human Raw Materials Market?
    North America was the largest region in the cell therapy human raw materials market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy human raw materials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    The Cell Therapy Human Raw Materials Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the cell therapy human raw materials market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Cell Therapy Human Raw Materials Market Include

    1. Cell Therapy Human Raw Materials Market Executive Summary
    2. Cell Therapy Human Raw Materials Market Segments
    3. Cell Therapy Human Raw Materials Market Size And Template Market Growth Rate
    4.  Key Cell Therapy Human Raw Materials Market Trends
    5. Major Cell Therapy Human Raw Materials Market Drivers
    ……
    25. Key Mergers And Acquisitions In The Cell Therapy Human Raw Materials Market
    26. Top Cell Therapy Human Raw Materials Companies
    27. Cell Therapy Human Raw Materials Market Opportunities And Strategies
    28. Cell Therapy Human Raw Materials Market, Conclusions And Recommendations
    29. Appendix

    Discover Related Reports by The Business Research Company:
    Cell And Gene Therapy Contract Development And Manufacturing Organization (CDMO) Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-contract-development-and-manufacturing-organization-cdmo-global-market-report

    Cell Regeneration Medicine Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/cell-regeneration-medicine-global-market-report

    Basal Cell Carcinoma Treatment Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/basal-cell-carcinoma-treatment-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:
    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Global Cell Therapy Human Raw Materials Market Report 2024 – Top Market Trends And Opportunities

    Global Cell Therapy Human Raw Materials Market Report 2024 – Top Market Trends And Opportunities

    The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

    The cell therapy human raw materials market has seen significant growth, driven by various factors including the increasing prevalence of chronic diseases, rising geriatric population, and high demand for regenerative medicines. This trend is expected to continue in the coming years.

    • 2023 to 2024 Market Expansion: The market size grew from $2.34 billion in 2023 to $2.81 billion in 2024, reflecting a CAGR of 20.1%.
    • Forecast for 2028: By 2028, the market is projected to reach $5.86 billion, maintaining a strong CAGR of 20.2%.

    Key Drivers of Market Growth
    Several factors contribute to the rapid expansion of the cell therapy human raw materials market.

    • Increasing Prevalence of Chronic Diseases: A rise in chronic health conditions such as cancer and diabetes necessitates advanced therapeutic solutions.
    • Rising Geriatric Population: An aging population fuels demand for treatments that can address age-related conditions.
    • High Demand for Regenerative Medicines: Advances in regenerative medicine offer promising solutions for tissue and organ repair.
    • Governmental Funding and Support: Increased investment in healthcare research and development propels market growth.
    • Growing Healthcare Expenditure: Rising healthcare spending globally supports the adoption of cutting-edge therapies.

    Rising Adoption of Regenerative Medicine
    Regenerative medicine is a key driver for the cell therapy human raw materials market, leveraging the body’s regenerative capabilities to treat various conditions.

    • Cell-Based Therapies: The use of stem cells and tissue engineering to repair and regenerate damaged tissues is gaining traction.
    • Standardized Treatments: Human raw materials are essential for creating reliable and effective cell-based therapies.
    • Global Growth: The number of cell, gene, and tissue-engineering therapeutic developers grew by 101% from Q1 2022 to Q1 2023.

    Read More On The Cell Therapy Human Raw Materials Market Report 2024 – https://www.thebusinessresearchcompany.com/report/cell-therapy-human-raw-materials-global-market-report

    Major Players in the Market
    Key companies are driving innovation and growth in the cell therapy human raw materials market.

    • Thermo Fisher Scientific Inc.: Expanded its market reach through the acquisition of PeproTech Inc.
    • Danaher Corporation: Leading in biotechnology solutions.
    • Merck KGaA and GE Healthcare: Major contributors to the global biopharmaceutical sector.
    • Lonza Group Ltd.: Innovating in cell culture mediums.

    Technological Advancements and Trends
    The market is witnessing several technological advancements that are set to shape its future.

    • Adoption of Allogeneic Therapies: These therapies use donor cells, which can be standardized for broader applications.
    • Integration of Artificial Intelligence: AI is being integrated into therapeutic development, enhancing precision and efficiency.
    • Off-the-Shelf Cell Therapies: Ready-made cell therapies are becoming more common, increasing accessibility.
    • 3D Bioprinting Technology: Revolutionizing the creation of complex tissue structures.
    • Development of Hybrid Cell Therapies: Combining different cell types for more effective treatments.

    Chemically Defined Mediums for Accelerated Development
    Leading companies are focusing on developing chemically defined cell culture mediums to advance cell therapy development.

    • TheraPEAK T-VIVO Cell Culture Medium: Launched by Lonza Group AG in May 2023, this medium is serum-free and animal component-free, supporting safe and consistent cell therapy manufacturing.
    • Regulatory Compliance: The emphasis on chemically defined formulations enhances safety and regulatory compliance.

    Thermo Fisher’s Strategic Acquisition of PeproTech
    Thermo Fisher Scientific’s acquisition of PeproTech Inc. for $1.85 billion in January 2022 has significantly impacted the market.

    • Enhanced Product Offerings: The acquisition expands Thermo Fisher’s recombinant protein portfolio.
    • Market Position: Strengthens its position in the biosciences sector, influencing the cell therapy human raw materials market.

    Market Segmentation and Regional Growth
    The cell therapy human raw materials market is segmented by product, type of cell therapy, and end-use.

    • By Product: Includes cell culture media, sera, supplements, reagents, buffers, and other raw materials.
    • By Type of Cell Therapy: Encompasses dendritic cell therapy, NK cell therapy, stem cell therapy, and T-cell therapy.
    • By End-Use: Serves biopharmaceutical and pharmaceutical companies, CROs, CMOs, and academic institutions.
    • Regional Insights: North America was the largest market in 2023, while Asia-Pacific is expected to be the fastest-growing region in the forecast period.

    Conclusion
    The cell therapy human raw materials market is poised for significant growth, driven by advancements in regenerative medicine, favorable regulatory frameworks, and technological innovations. With major companies leading the charge, the market is set to expand rapidly in the coming years, offering promising opportunities for stakeholders across the healthcare sector.

    Request for A Sample Of The Global Cell Therapy Human Raw Materials Market Report:
    https://www.thebusinessresearchcompany.com/sample_request?id=15759&type=smp